首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Immunophenotypic Polymorphisms of Donor Origin Having Effect on the Recipient MRD Detection by Flow Cytometry after Allogeneic Hematopoietic Stem Cell Transplantation

【24h】

Immunophenotypic Polymorphisms of Donor Origin Having Effect on the Recipient MRD Detection by Flow Cytometry after Allogeneic Hematopoietic Stem Cell Transplantation

机译：在同种异体造血干细胞移植后流式细胞术对受体MRD检测有效的免疫蛋白型多态性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2018年第3期|共2页
作者
Hui Wang;
展开▼
作者单位

Hematopathology Hebei Yanda Lu Daopei Hospital;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Immunophenotypic Polymorphisms of Donor Origin Having Effect on the Recipient MRD Detection by Flow Cytometry after Allogeneic Hematopoietic Stem Cell Transplantation [J] . Hui Wang Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：None
2. Monitoring MRD with flow cytometry: An effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation [J] . ZhaoX.-S., LiuY.-R., ZhuH.-H., Annals of hematology . 2012,第2期

机译：流式细胞仪监测MRD：预测异基因造血干细胞移植后所有患者复发的有效方法
3. Monitoring MRD with flow cytometry: an effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation [J] . Xiao-Su Zhao, Yan-Rong Liu, Hong-Hu Zhu, Annals of Hematology . 2012,第2期

机译：流式细胞仪监测MRD：预测异基因造血干细胞移植后所有患者复发的有效方法
4. Circulating Tumor DNA Predicts Post-Allogeneic Hematopoietic Stem Cell Transplantation in AML and MDS [C] . Sousuke Nakamura International Molecular Medicine Tri-Conference. . 2019

机译：循环肿瘤DNA预测AML和MDS中的同种异体造血干细胞移植
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. The Prognostic Value of Early Detection of Minimal Residual Disease as Defined by Flow Cytometry and Gene Mutation Clearance for Myelodysplastic Syndrome Patients After Myeloablative Allogeneic Hematopoietic Stem-Cell Transplantation [O] . Chang Hou, Lili Zhou, Menglu Yang, 2021

机译：流式细胞术术及基因突变清除霉菌异化造血干细胞移植后流式细胞术及基因突变清关髓细胞增生综合征患者的早期检测预后值
7. Prospective Evaluation of A ‘Two-Pronged’ Strategy of Atorvastatin Administration As Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis, to Both Donors and Recipients of Matched Related Donor (MRD) Allogeneic Hematopoietic Cell Transplantation (alloHCT) [O] . Hamadani Mehdi, Gibson Laura F., Remick Scot C., 2013

机译：对阿托伐他汀作为急性移植物抗宿主病（aGVHD）预防的“两管齐下”策略的前瞻性评估，同时向同种相关供体（MRD）同种异体造血细胞移植（alloHCT）的受者

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号